Year of investment:
2021

Turnover:
SEK 200m

Fund:
Priveq Investment VI

Ownership:
Minority

CEO:
Martin Sjögren

Phone:
+46 13 37 40 30

Swemac

Swemac strives continuously to provide the market with innovative and practical solutions for fracture treatment and joint replacement to benefit patients and health care professionals. Swemac has evolved over the years within a highly innovative environment where quality has always been critical to development and production. This strong tradition of innovation and high quality remains a core characteristic and guiding compass for Swemac today. The products are currently sold via Swemac’s own sales organization in the Nordics and through distributors on international markets. Also 3rd party brands within trauma treatment and medical imaging are distributed by Swemac in the Nordics.

The company is headquartered in Linköping and has ca 80 employees.

Members of the Board
Ulf Mattsson (Chairman of the Board), Karl Hagström, Henrik Hansson, Mattias Hansson, Anders Nilsson, Senai Ayob

Priveq team
Senai Ayob, Magnus Hardmeier, Daniel Nylund

For further information, please contact

Senai Ayob
Partner & Investment Manager
Telefon: +46 8 459 67 69
Mobil: +46 70 459 23 61
E-post: senai.ayob@priveq.se

Related news

NewsSwemac - EN

Priveq – new growth partner to Swemac

Swemac Innovation AB (“Swemac”), a developer of innovative solutions for fracture treatment and joint replacement with a focus on hips and upper extremities, welcomes Priveq Investment (“Priveq”) as new minority owner to support the company in its accelerated growth strategy.…
20/01/2021
  • Previous ProjectROL

  • Next ProjectIndustri-Matematik